OBJECTIVE: The risk of cardiovascular disease increases after menopause. Recent evidence suggests that it is possible for high-density lipoprotein (HDL) to become proatherogenic or dysfunctional in certain situations. Our objective was to evaluate whether the relationship of HDL cholesterol (HDL-C) to subclinical cardiovascular disease differed across the menopausal transition, which would provide insight for this increased risk. METHODS: Aortic calcification (AC), coronary artery calcification (CAC), carotid plaque, and intima media thickness (IMT) were measured in an ancillary study of the Study of Women's Health Across the Nation. Women not using hormone therapy were stratified into premenopausal or early perimenopausal (Pre/EP, n=316) and late perimenopausal or postmenopausal (LP/Post, n=224). RESULTS: The inverse relationship of HDL-C to subclinical atherosclerosis measures among Pre/EP women was weaker or reversed among LP/Post women, adjusted for age, site, race, systolic blood pressure, glucose, body mass index, smoking, menopause status, and low-density lipoprotein cholesterol. Specifically, multivariable modeling demonstrated an inverse association between HDL-C level and AC and IMT among Pre/EP women; however, the protective effect of HDL-C for AC, left main CAC, carotid plaque, and IMT was not seen in LP/Post women. In a small subset (n=53), LP/Post women had more total and small HDL particles, higher triglyceride levels, and more total low-density lipoprotein particles compared with Pre/EP women (P<0.05). CONCLUSIONS: These results suggest that the protective effect of HDL may be diminished as women transition in menopause. Future studies should examine whether this may be due to changes in HDL size, functionality, or related changes in other lipids or lipoproteins.
OBJECTIVE: The risk of cardiovascular disease increases after menopause. Recent evidence suggests that it is possible for high-density lipoprotein (HDL) to become proatherogenic or dysfunctional in certain situations. Our objective was to evaluate whether the relationship of HDL cholesterol (HDL-C) to subclinical cardiovascular disease differed across the menopausal transition, which would provide insight for this increased risk. METHODS:Aortic calcification (AC), coronary artery calcification (CAC), carotid plaque, and intima media thickness (IMT) were measured in an ancillary study of the Study of Women's Health Across the Nation. Women not using hormone therapy were stratified into premenopausal or early perimenopausal (Pre/EP, n=316) and late perimenopausal or postmenopausal (LP/Post, n=224). RESULTS: The inverse relationship of HDL-C to subclinical atherosclerosis measures among Pre/EP women was weaker or reversed among LP/Post women, adjusted for age, site, race, systolic blood pressure, glucose, body mass index, smoking, menopause status, and low-density lipoprotein cholesterol. Specifically, multivariable modeling demonstrated an inverse association between HDL-C level and AC and IMT among Pre/EP women; however, the protective effect of HDL-C for AC, left main CAC, carotid plaque, and IMT was not seen in LP/Post women. In a small subset (n=53), LP/Post women had more total and small HDL particles, higher triglyceride levels, and more total low-density lipoprotein particles compared with Pre/EP women (P<0.05). CONCLUSIONS: These results suggest that the protective effect of HDL may be diminished as women transition in menopause. Future studies should examine whether this may be due to changes in HDL size, functionality, or related changes in other lipids or lipoproteins.
Authors: G Berg; V Mesch; L Boero; F Sayegh; M Prada; M Royer; M L Muzzio; L Schreier; N Siseles; H Benencia Journal: Horm Metab Res Date: 2004-04 Impact factor: 2.936
Authors: D de Aloysio; M Gambacciani; M Meschia; F Pansini; A Bacchi Modena; P F Bolis; M Massobrio; G Maiocchi; E Peruzzi Journal: Atherosclerosis Date: 1999-11-01 Impact factor: 5.162
Authors: Susan A Everson-Rose; Tené T Lewis; Kelly Karavolos; Karen A Matthews; Kim Sutton-Tyrrell; Lynda H Powell Journal: Am Heart J Date: 2006-11 Impact factor: 4.749
Authors: Carol A Derby; Sybil L Crawford; Richard C Pasternak; Maryfran Sowers; Barbara Sternfeld; Karen A Matthews Journal: Am J Epidemiol Date: 2009-04-08 Impact factor: 4.897
Authors: Bela F Asztalos; Dorothea Collins; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst J Schaefer Journal: Metabolism Date: 2008-01 Impact factor: 8.694
Authors: V J Victorino; C Panis; F C Campos; R C Cayres; A N Colado-Simão; S R Oliveira; A C S A Herrera; A L Cecchini; R Cecchini Journal: Age (Dordr) Date: 2012-05-28
Authors: Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke Journal: J Clin Endocrinol Metab Date: 2016-07-11 Impact factor: 5.958
Authors: Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel Journal: J Womens Health (Larchmt) Date: 2018-12-01 Impact factor: 2.681
Authors: Melissa N Martinez; Christopher H Emfinger; Matthew Overton; Salisha Hill; Tara S Ramaswamy; David A Cappel; Ke Wu; Sergio Fazio; W Hayes McDonald; David L Hachey; David L Tabb; John M Stafford Journal: J Lipid Res Date: 2012-01-03 Impact factor: 5.922
Authors: Rebecca C Thurston; Samar R El Khoudary; Kim Sutton-Tyrrell; Carolyn J Crandall; Ellen B Gold; Barbara Sternfeld; Hadine Joffe; Faith Selzer; Karen A Matthews Journal: Obstet Gynecol Date: 2012-04 Impact factor: 7.661
Authors: Bradley M Appelhans; Eisuke Segawa; Imke Janssen; Lisa M Nackers; Rasa Kazlauskaite; Ana Baylin; John W Burns; Lynda H Powell; Howard M Kravitz Journal: Prev Med Date: 2014-12-06 Impact factor: 4.018
Authors: Samar R El Khoudary; Lin Wang; Maria M Brooks; Rebecca C Thurston; Carol A Derby; Karen A Matthews Journal: J Clin Lipidol Date: 2016-04-26 Impact factor: 4.766
Authors: Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary Journal: J Clin Lipidol Date: 2020-07-08 Impact factor: 4.766